Advanced search
Publication Cover
Patient Related Outcome Measures Volume 9, 2018 - Issue
Submit an article Journal homepage
140
Views
10
CrossRef citations to date
0
Altmetric
Review

Sarilumab: patient-reported outcomes in rheumatoid arthritis

Chiara Crotti1 Department of Clinical Sciences and Health Community, University of Milan;2 Division of Rheumatology, Gaetano Pini Institute, Milan, Italy
,
Martina Biggioggero3 Department of Rheumatology, Gaetano Pini Institute, Milan, Italy, [email protected]
,
Andrea Becciolini3 Department of Rheumatology, Gaetano Pini Institute, Milan, Italy, [email protected]
&
Ennio Giulio Favalli3 Department of Rheumatology, Gaetano Pini Institute, Milan, Italy, [email protected]Correspondence[email protected]
Pages 275-284 | Published online: 20 Aug 2018

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gabriella Maioli, Roberto Caporali & Ennio Giulio Favalli. (2022) Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis. Expert Opinion on Drug Discovery 17:8, pages 799-813.
Read now
Martina Biggioggero, Chiara Crotti, Andrea Becciolini & Ennio Giulio Favalli. (2019) Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection. Drug Design, Development and Therapy 13, pages 57-70.
Read now

Articles from other publishers (8)

Qian Ding, Wei Hu, Ran Wang, Qinyan Yang, Menglin Zhu, Meng Li, Jianghong Cai, Peter Rose, Jianchun Mao & Yi Zhun Zhu. (2023) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Gerd R Burmester, Vivian P Bykerk, Maya H Buch, Yoshiya Tanaka, Hideto Kameda, Amy Praestgaard, Hubert van Hoogstraten, Antonio Fernandez-Nebro & Thomas Huizinga. (2022) Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis . Rheumatology 61:6, pages 2596-2602.
Crossref
Eva M. Sánchez-Robles, Rocío Girón, Nancy Paniagua, Carmen Rodríguez-Rivera, David Pascual & Carlos Goicoechea. (2021) Monoclonal Antibodies for Chronic Pain Treatment: Present and Future. International Journal of Molecular Sciences 22:19, pages 10325.
Crossref
E. L. Nasonov, T. A. Lisitsyna, E. V. Zonova & S. M. Kuzkina. (2021) The effect of olokizumab on rheumatoid arthritis patient’s reported outcomes: results of a double-blind randomized placebo-controlled multicenter phase III trial (CREDO 1). Rheumatology Science and Practice 59:1, pages 62-69.
Crossref
Manivel Rengasamy & Rebecca B. Price. 2021. The Neuroscience of Depression. The Neuroscience of Depression 119 125 .
Ennio G. Favalli. (2020) Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis. Rheumatology and Therapy 7:3, pages 473-516.
Crossref
May N. Lwin, Lina Serhal, Christopher Holroyd & Christopher J. Edwards. (2020) Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review. Rheumatology and Therapy 7:3, pages 457-471.
Crossref
E. L. Nasonov & A. M. Lila. (2019) The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence. Rheumatology Science and Practice 57:5, pages 564-577.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.